Scarica l'app Stockscreener
226.36
0.87%
1.62
Natera Inc Borsa (NTRA) Ultime notizie
Can Natera Inc. stock beat analyst upgradesJuly 2025 Snapshot & Weekly High Return Opportunities - DonanımHaber
Is Natera’s 425.8% Three Year Surge Still Supported by Its Growth Story in 2025? - simplywall.st
Profit Recap: Will Natera Inc. stock outperform tech sector in 20252025 Biggest Moves & Growth Focused Entry Point Reports - Улправда
NTRA: Natera's Phase III Study Highlights Celecoxib's Efficacy i - GuruFocus
Study shows celecoxib improves survival in certain colorectal cancer patients - Investing.com India
Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer - Yahoo Finance
Is Natera Inc. stock attractive after correctionJuly 2025 Opening Moves & Weekly Chart Analysis and Guides - Улправда
Thrivent Financial for Lutherans Cuts Stake in Natera, Inc. $NTRA - MarketBeat
Assenagon Asset Management S.A. Purchases 80,684 Shares of Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) director and co-founder discloses stock gift and sales - Stock Titan
Dir Sheena Sells 3,070 ($696.9K) Of Natera Inc [NTRA] - TradingView — Track All Markets
Natera’s Signatera Test Gains Validation in Key Breast Cancer Study - AD HOC NEWS
Dir Sheena Files To Sell 9,210 Of Natera Inc [NTRA] - TradingView — Track All Markets
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail
Natera, Inc.'s (NASDAQ:NTRA) Business Is Trailing The Industry But Its Shares Aren't - 富途牛牛
Solomon Moshkevich Sells 4,692 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 48,419 Shares of Stock - MarketBeat
Officer Moshkevich Acquires 17,684 Of Natera Inc [NTRA] - TradingView — Track All Markets
NATERA INC : JEFFERIES RAISES TARGET PRICE TO $275 FROM $230 - 富途牛牛
Natera’s cancer test improves risk assessment in breast cancer patients By Investing.com - Investing.com Nigeria
Natera, Inc. $NTRA Shares Bought by New England Research & Management Inc. - MarketBeat
Natera (NASDAQ: NTRA) I-SPY 2 study ties Signatera ctDNA status to 3-year DRFS, recurrence risk - Stock Titan
NeoGenomics (NEO): Assessing Valuation After Legal Win Over Natera and New Oncology Data Releases - simplywall.st
Jefferies raises Natera stock price target to $275 on oncology growth - Investing.com Nigeria
Natera (NTRA) director logs RSU grant and stock sales near $228 per share - Stock Titan
Barclays Raises Natera (NTRA) Price Target to $270 | NTRA Stock News - GuruFocus
NTRA: JP Morgan Raises Price Target to $260 with Overweight Rati - GuruFocus
Natera (NASDAQ:NTRA) Given New $260.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Natera dismisses appeal in patent case against NeoGenomics By Investing.com - Investing.com Nigeria
Natera dismisses appeal in patent case against NeoGenomics - Investing.com India
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litig - pharmiweb.com
NeoGenomics Says Natera Withdraws Appeal in Patent Case - marketscreener.com
Neogenomics announces that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation - marketscreener.com
Neogenomics Announces That Natera Has Voluntarily Withdrawn Its Appeal In Ongoing RaDaR Patent Litigation - TradingView — Track All Markets
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
Marex Group plc Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Castleark Management LLC Has $5.87 Million Stake in Natera, Inc. $NTRA - MarketBeat
Wells Fargo maintains Natera (NTRA) equal-weight recommendation - MSN
Natera (NTRA): Assessing Valuation After Strong Multi‑Year Share Price Rally - simplywall.st
Holocene Advisors LP Boosts Stake in Natera, Inc. $NTRA - MarketBeat
Fullerton Fund Management Co Ltd. Has $1.05 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Nikko Asset Management Americas Inc. - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Engineers Gate Manager LP Sells 30,042 Shares of Natera, Inc. $NTRA - MarketBeat
GCM Grosvenor Holdings LLC Sells 6,475 Shares of Natera, Inc. $NTRA - MarketBeat
Gilder Gagnon Howe & Co. LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Bellevue Group AG Raises Stock Position in Natera, Inc. $NTRA - MarketBeat
AQR Capital Management LLC Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Officer Moshkevich Files To Sell 4,692 Of Natera Inc [NTRA] - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - The Globe and Mail
Caption Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Joins Phase II Breast Cancer Study with Innovative DNA Testing - GuruFocus
Maverick Capital Ltd. Reduces Position in Natera, Inc. $NTRA - MarketBeat
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer - Yahoo Finance
Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know - MSN
Dir Sheena Acquires 4,436 Of Natera Inc [NTRA] - TradingView — Track All Markets
Natera Completes Acquisition Of Foresight Diagnostics For Up To $450 Million - Pulse 2.0
Natera New Test Data Could Change How Doctors Manage Breast CancerNatera (NASDAQ:NTRA) - Benzinga
Is It Too Late to Consider Natera After a 511% Three Year Surge? - simplywall.st
Natera stock rating reiterated at Buy by TD Cowen on solid momentum - Investing.com India
Is It Too Late To Consider Natera After Its Recent 12.8% Price Surge? - Yahoo Finance
California Public Employees Retirement System Purchases 29,296 Shares of Natera, Inc. $NTRA - MarketBeat
Frontier Capital Management Co. LLC Has $65.04 Million Position in Natera, Inc. $NTRA - MarketBeat
0.24%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):